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Abstract
Background: Uterine receptivity and embryo implantation are critical in the establishment of
pregnancy. The diagnosis of endometrial fertility requires more precise measurements of
endometrial receptivity. Interleukin (IL-11) and leukemia inhibitory factor (LIF) are essential for
murine implantation and signal via intracellular phosphorylation (p) of STAT3 in the endometrium.
Both cytokines are present in the endometrium of women duiring the receptive window.
Endometrial IL-11, IL-11 receptor alpha (IL-11Ralpha), LIF and pSTAT3 in women with primary
unexplained infertility was compared to normal fertile women during the implantation window.
Methods: LH timed endometrial biopsies (LH+6 to LH+10) were collected from women with
unexplained infertility and normal fertility. pSTAT3, IL-11, IL-11Ralpha and LIF production was
determined by immunohistochemistry. Staining intensity was determoned by two independent
observers blind to the fertility status of the patient from whom the biopsy was taken. Staining
intensity and heterogeneity in each of the endometrial compartments (epithelium; stroma, including
decidualized stromal cells; and vasculature) was assessed. The Mann-Whitney U test was used to
analyze IL-11, pSTAT3, IL-11Ralpha and LIF immunostaining intensities in the samples.
Results: IL-11, IL-11Ralpha and LIF were present predominantly in glandular epithelium, whilst
luminal epithelium showed patchy staining. pSTAT3 was present in both glandular epithelium and
stroma. IL-11 and pSTAT3 immunostaining was significantly lower in glandular epithelium in infertile
women compared to controls (P < 0.05) whilst IL-11Ralpha and LIF staining did not differ.
Conclusion: This is the first demonstration of reduced endometrial pSTAT3 and IL-11 in some
women with unexplained infertility. This suggests IL-11 and pSTAT3 may be involved in the
secretory transformation of glandular epithelium during receptivity. Reduced IL-11 production and
STAT3 phosphorylation may contribute to unexplained infertility in some women.
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Background
Embryo implantation into the uterus is a critical step in
the establishment of pregnancy and failure of this process
is a major cause of infertility in women [1].
Endometrium is receptive to the embryo for a short time-
period, after exposure to 17-β-estradiol followed by pro-
gesterone [2]. Embryo transfer studies in women and pri-
mates have identified the phase of uterine receptivity, the
'window of implantation', between post-ovulatory days
5–10 [3] following the luteinizing hormone (LH) surge.
Implantation of the embryo between post-ovulatory days
8–10 has a high chance of resulting in a successful preg-
nancy [4]. Unexplained infertility accounts for approxi-
mately 30% of all infertility [5,6]. Defective uterine
receptivity is thought to be a primary cause of unex-
plained infertility. Unexplained or primary infertility is
likely due to multiple defects as it has been associated
with numerous molecular and cellular disturbances in the
endometrium [7,8].
Interleukin-11 (IL-11) and LIF belong to the interleukin-6
(IL-6) family of cytokines whose members exhibit pleiot-
ropy and redundancy, with many overlapping functions
[9]. IL-11 binds to IL-11 receptor (IL-11 Rα) and initiates
signalling whilst LIF signals by binding to the specific LIF
receptor α (LIFR). Each ligand-receptor complex forms a
hetero-dimer with gp130, the common transmembrane
signal transducer. In the endometrium, intracellular sig-
nalling occurs via activation of the janus kinase (JAK)/sig-
nal transducers and activators of transcription (STAT)
pathway [10-12]. IL-11 and LIF are part of an exclusive
group of genes that are essential for implantation in mice
[13]. Both endometrial IL-11 and LIF are obligatory for
implantation in mice [14-16]. STAT3 also has an impor-
tant role in implantation in mice [10,17]. Blockade of
phosphorylated (p) STAT3 at the time of embryo attach-
ment reduces implantation rates in mice [18,19].
Although the role of LIF in human endometrial receptivity
has been previously studied the results are conflicting
[8,20]. There are very few studies examining the role of IL-
11 and no studies for pSTAT3 in infertility in women [21].
IL-11, LIF and pSTAT3 are expressed by endometrial, glan-
dular and luminal epithelium in the mid-secretory phase
of the menstrual cycle in women [22-25]. Similarly, mid-
secretory phase luminal and glandular epithelium express
gp130, LIFRα and IL-11Rα [22,24,26,27]. Immunoreac-
tive LIF is reduced in endometrial biopsies from infertile
women [28], while uterine flushings contain maximum
levels of LIF protein during the mid to late secretory phase
of the menstrual cycle [29-31]. In addition, LIF is reduced
in uterine flushings from women with primary infertility
compared to fertile controls [29-31]. Similarly, IL-11 is
present in uterine fluid [32]. These studies suggest IL-11
and LIF are secreted by the uterine glandular epithelium
into the uterine lumen where they could act on the blast-
ocyst or the endometrial luminal epithelium to facilitate
blastocyst attachment and implantation.
In addition, in some women with endometriosis associ-
ated infertility, IL-11 and LIF immunoreactivity are
reduced in glandular epithelium suggesting that both
cytokines may also contribute to the pathology of infertil-
ity of unknown cause [12]. While, IL-11 and LIF expres-
sion is spacially and temporally distinct in mice, they are
both present in glandular epithelium and utilize similar
signal transduction pathways at the time of implantation
in women. It is important to determine whether they
potentially act in a redundant manner. In a previous
study, while LIF production was not different between
women with unexplained infertility and normal fertile
women, there was reduced secretion of soluble gp130
from endometrial explants. This indicates it is important
to also examine IL-11 and LIF's signalling components
together with the production of the ligands. pSTAT3 is of
particular interest since it has an important role in
implantation in mice. There are no studies examining the
production of IL-11 and pSTAT3 in endometrium of
women with primary unexplained infertility.
We hypothesized that IL-11, IL-11Rα, LIF and pSTAT3 are
dysregulated in endometrium from women with unex-
plained infertility during the 'window of implantation'.
Endometrial protein abundance for IL-11, pSTAT3, IL-
11Rα and LIF was compared in women with primary
unexplained infertility and normal fertile women.
Methods
Participants and endometrial biopsies
Endometrial biopsies were collected from women with
primary unexplained infertility of more than 2 years dura-
tion (n = 10, age 25–40 yr) and fertile age matched con-
trols (n = 9, age 25–40 yr) between days LH+ 6 to LH+10.
All women had regular menstrual cycles of 26–32 days,
were not using intra-uterine contraceptives and had not
used hormones for at least three months prior to surgery.
Women with infertility who had partners with male factor
infertility were not included in the study. The women with
infertility did not have ovulation or tubal patency defects
and endometriosis. All infertile patients and controls had
negative laparoscopies. All women biopsied in the secre-
tory phase of the menstrual cycle, performed home uri-
nary LH surge tests and all biopsies were histologically
dated according to the Noyes criteria [33]. Written
informed consent was obtained from all patients before
their operations and protocols were approved by Institu-
tional Ethical committees, namely Southern Health
Human Ethical Committee and Addenbrooke's Hospital
NHS Trust. Ethical approval was also obtained fromReproductive Biology and Endocrinology 2007, 5:44 http://www.rbej.com/content/5/1/44
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Southern Health Human Ethics Committee, Melbourne,
Australia.
Immunohistochemistry
Tissues were stained for IL-11 and IL-11Rα with mouse
anti-huIL-11 (clone 5E3) and mouse anti-huIL-11Rα
(clone 4D12) antibodies (generous gifts from Dr Lorraine
Robb) as previously described [23]. Briefly, dewaxed,
rehydrated sections were incubated with blocking solu-
tion containing 10% horse serum (Sigma Aldrich Inc. Mis-
souri, USA), 5% human serum and Tris Buffered saline
(TBS) (pH 7.4) for 30 min. Primary antibodies were
applied diluted to 5 µg/ml (IL-11) and 2.5 µg/ml (IL-
11Rα) in blocking solution for 18 h at 4°C. Antibody
localization was detected by sequential application of
biotinylated horse anti-mouse IgG (Vector Laboratories,
Burlingame, CA, USA) in blocking solution, followed by
an avidin-biotin complex conjugated to HRP (Vectastain
ABC Elite kit; Vector Laboratories).
LIF protein was immunostained using antiserum against
human LIF protein raised in rabbit (AMRAD Pharmacia
Biotech, Boronia, Vic., Australia) as previously described
[23]. The primary antibody (1:2000) was applied on the
tissues for 12 h at RT. The slides were washed, biotinylated
swine anti-rabbit IgG (DAKO, Glostrup, Denmark;)
applied, followed by streptavidin-biotin-peroxidase com-
plex (Vector Laboratories Inc., Burlingame, CA, USA)
according to the manufacturer's instructions.
Tissues were stained for pSTAT3 as previously described
using rabbit polyclonal antibodies raised against human
peptides (R&D Systems Inc.) [12]. Briefly, sections were
preincubated with 10% non-immune horse serum
(Sigma-Aldrich, Sydney, Australia), 2% normal human
serum (in-house) in TBS and 0.1% Tween 20. Primary
antibodies were applied overnight (17 h) at 4°C diluted
to 4 µg/ml in non-immune block. Detection of positive
binding was performed by the sequential application of
biotinylated goat anti-rabbit IgG; (Vector Laboratories)
and avidin-biotin-peroxidase conjugate (Dako, Glostrup,
Denmark).
In all cases the substrate used was diaminobenzidine
(DAB) (Zymed, San Francisco, USA). A section from a sin-
gle block of first trimester decidua was included in each
staining run for quality control and an isotype-matched
negative control at the same protein concentration as the
primary antibody, was included for each tissue. The
immunohistochemistry procedure was conducted at least
twice for each tissue and each ligand/receptor.
Assessment of immunostaining
Immunostaining was analyzed semi-quantitatively by two
independent observers blind to the fertility status of the
patient from whom the biopsy was taken. Staining inten-
sity and heterogeneity in each of the endometrial com-
partments (epithelium; stroma and vasculature) was
assessed and allocated a score between 0 and 3 where
numbers represent, 0: no stain, 1: faint, 2: moderate and
3: strong, relative to positive and negative controls.
Statistics
Results are expressed as mean ± SEM. The Mann-Whitney
U test was used to analyze IL-11, IL-11Rα and LIF immu-
nostaining in the infertile and fertile control samples. Dif-
ferences were considered statistically significant when P <
0.05.
Results
Endometrial IL-11, IL-11Rα and LIF immunostaining in 
women with primary infertility and fertile controls 
between days LH+6 to +10
IL-11 staining was largely confined to the glandular epi-
thelium in the endometrial tissue (Figure 1A and 1B). IL-
11 immunoreactivity was moderate to high in glandular
epithelial cells from all control fertile women and some
infertile women (Figure 1A and 1B and Figure 2A). How-
ever, mean IL-11 staining in glandular epithelium was
consistently more intense in tissues from control women
compared to the infertile women (1.7 ± 0.2 vs 1.1 ± 0.2
respectively, P < 0.05) (Figure 2A), although there was a
clear overlap between the groups. Minimal staining for IL-
11 was observed in the stromal compartment in tissues
from fertile and infertile women (Figure 1A and 1B).
Seven tissues from both infertile and control fertile
women contained luminal epithelium. IL-11 staining in
luminal epithelium was low-moderate and did not differ
between infertile and control groups (data not shown).
There was no correlation with staining intensity and
women's age (data not shown).
Similarly, IL-11Rα staining in endometrial tissues was
present predominantly in glandular epithelial cells (Fig-
ure 1C and 1D). While all tissues from control and infer-
tile women stained for IL-11Rα, the intensity ranged from
minimal to high and was not different between infertile
and fertile women (Figure 2B). IL-11Rα staining was low
in stromal and vascular cells in all tissues and did not dif-
fer between the groups (data not shown).
LIF staining was maximal in glandular epithelium and
minimal in the stromal compartment in the biopsies (Fig-
ure 1E and 1F). LIF staining intensity in glandular epithe-
lial cells was variable within the tissues from both infertile
and fertile women. It ranged from low to maximal and did
not differ between the two groups (Figure 2C).Reproductive Biology and Endocrinology 2007, 5:44 http://www.rbej.com/content/5/1/44
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Endometrial pSTAT3 immunostaining in women with 
primary infertility and fertile controls between days LH+6 
to +10
We aimed to examine whether pSTAT3 was reduced in
endometrium of women with infertility compared to nor-
mal fertile women. We also aimed to determine whether
pSTAT3, IL-11's main down stream target molecule was
reduced in the same women that we observed a reduction
in IL-11 immunostaining. pSTAT3 staining was present in
endometrial glandular epithelium and stroma (Figure
3A–C). pSTAT3 immunoreactivity ranged from absent to
moderate in glandular epithelium of infertile women
(Figure 3A–B and 4A). Mean pSTAT3 staining in glandular
epithelium was consistently more intense in tissues from
control women compared to the infertile women (1.3 ±
0.3 vs 0.4 ± 0.2 respectively, P < 0.05) (Figure 4A). No cor-
relation was found between IL-11 and pSTAT3 staining
intensity in the glandular epithelium (data not shown).
Minimal to high staining for pSTAT3 was observed in the
stromal compartment in tissues from fertile and infertile
women and was not different between the groups of
women (Figure 3A–C and 4A–B). Seven out of the ten
women with infertility had very low levels of both IL-11
and pSTAT3 protein in the glandular epithelium (data no
shown). Seven tissues from both infertile and control fer-
tile women contained luminal epithelium. However,
pSTAT3 staining in luminal epithelium was present in one
tissue from the infertile group and two tissues from the
control group (Figure 3E and 3F)
Discussion
We demonstrated for the first time that IL-11 and pSTAT3
immunoreactivity in uterine glandular epithelium was
decreased in women with unexplained infertility.
We observed a significant decrease in IL-11 and pSTAT3 in
uterine glandular epithelium in some women with infer-
tility compared to normal cycling fertile women. Unex-
Photomicrographs representing immunostaining for IL-11, IL-11Rα and LIF of human endometrium from fertile controls and  women with primary infertility Figure 1
Photomicrographs representing immunostaining for IL-11, IL-11Rα and LIF of human endometrium from fertile controls and 
women with primary infertility. Positive staining is shown as brown pigment with blue nuclear hematoxylin counterstain. Mag-
nification ×200. (A-B) IL-11 staining. (A) Day LH+6 tissue from woman with infertility. (B) Day LH+6 tissue from fertile woman. 
(C-D) IL-11Rα staining. (C) Day LH+8 tissue from woman with infertility. (D) Day LH+8 tissue from control fertile woman. (E-
F) LIF staining. (E) Day LH+8 tissue from fertile woman. (F) Day LH+8 tissue from infertile woman.
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plained infertility is likely caused by several defects
therefore it is not surprising that we identified cohorts of
infertile women with defective IL-11 and pSTAT3 produc-
tion. IL-11 could be acting on the glandular epithelium to
facilitate its secretory transformation. In addition, IL-11
has been identified in the uterine lumen of women [32].
IL-11 present in the uterine lumen could act on the
endometrial uterine epithelium to facilitate attachment or
adhesion of the blastocyst.
Low glandular pSTAT3 may be due to either reduced
STAT3 protein production and/or factors that stimulate
STAT3 phosphorylation. IL-11 and LIF are known to sig-
nal via STAT3 in endometrium [10,25]. Interestingly,
glandular epithelium from women with infertility that
had low IL-11 staining did not consistently have low
pSTAT3 staining. LIF protein levels did not correlate with
pSTAT3 levels in glandular epithelium. This suggests fac-
tors other than these cytokines regulate STAT3 protein
activation. It is also plausible that IL-11 and LIF stimulate
pSTAT3 in glandular epithelium but the levels of STAT3
protein may be low in glandular epithelium of some infer-
tile women. Numerous factors including progestins stim-
ulate pSTAT3 and STAT3 [9,34]. The regulation of pSTAT3
Immunostaining for IL-11, IL-11Rα and LIF in endometrial glandular epithelium from normal fertile women and women with  primary infertility between days LH+6- +10 of the menstrual cycle Figure 2
Immunostaining for IL-11, IL-11Rα and LIF in endometrial glandular epithelium from normal fertile women and women with 
primary infertility between days LH+6- +10 of the menstrual cycle. Relative staining intensities are represented as 0 (no stain-
ing) to 3 (high). (A) IL-11 staining. (B) IL-11Rα staining (C) LIF staining. Women with primary infertility (infertile) (n = 10). Con-
trol normal fertile women (fertile) (n = 9). Individual data shown for each parameter. Bar represents the mean value. * P < 0.05 
compared to fertile control.
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and STAT3 in the uterine glandular epithelium remain to
be elucidated.
Minimal pSTAT3 staining was found in eight of the ten
infertile women. If the levels of pSTAT3 in some women
was due to reduced STAT3 protein abundance this could
result in inadequate LIF and IL-11 action. While LIF was
not significantly reduced in the endometrial glands of
women with infertility, LIF action could be impaired in
women with low glandular pSTAT3. Similarly, some
women had moderate to high IL-11 and low pSTAT3 in
the glands. This could similarly result in abnormal IL-11
action. Further studies are required to determine the
mechanisms of action of IL-11 and LIF in endometrial epi-
thelium. In addition, LIF levels did not differ in uterine
glandular epithelium between infertile and fertile women
Photomicrographs representing endometrial pSTAT3 immunostaining in women with primary infertility and fertile women Figure 3
Photomicrographs representing endometrial pSTAT3 immunostaining in women with primary infertility and fertile women. 
Magnification ×200. (A and B) pSTAT3 immunostaining of endometrium from women with primary infertility. (A) Day LH+7 
(B) Day LH+9. (C) Control fertile women day LH+6, pSTAT3 staining. (D) Day LH+10 tissue showing negative control for 
pSTAT3 staining. (E) Infertile women at day LH+8 showing pSTAT3 staining of luminal epithelium (F) Control fertile women at 
Day LH+7 showing luminal epithelium-pSTAT3.
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indicating IL-11 and LIF may have different roles in
women with unexplained infertility.
In contrast to the present study IL-11, IL-11Rα and LIF
staining were decreased in glandular epithelial cells in
women with endometriosis associated infertility [12].
This suggests the endometrial phenotype of women with
primary infertility differs from that of women with
endometriosis associated infertility. It is likely that differ-
ent therapeutic strategies may be necessary to treat
endometrial implantation failure depending upon aetiol-
ogy.
IL-11, pSTAT3, IL-11Rα and LIF staining was overall low
and patchy or absent in luminal epithelium of both infer-
tile and fertile women. Few tissues contained luminal epi-
thelium making it difficult to analyze the
immunostaining in this cellular compartment.
IL-11 like LIF is present in the uterine secretome indicat-
ing both could act on the blastocyst or the surface luminal
epithelium. The human blastocyst expresses gp130 and
LIFRα [35] but whether it also expresses IL-11Rα is not
known. Although the function of IL-11 and pSTAT3 in
endometrial glands needs to be elucidated, unexplained
infertility in some women may be due to reduced levels of
either IL-11 or pSTAT3.
Conclusion
Importantly, our study indicates that reduced pSTAT3 and
IL-11 are associated with unexplained infertility and play
a role in the secretory transformation of uterine glandular
epithelium during the receptivity. The factors that regulate
the deficiency in IL-11 and pSTAT3 and the functional
consequence of this in endometrial epithelium remain to
be explored. Understanding the mechanisms of IL-11 and
pSTAT3 action in endometrial epithelium may provide
new therapeutic strategies for unexplained infertility.
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Immunostaining for pSTAT3 in endometrial glandular epithelium and stroma from normal fertile women and women with pri- mary infertility between days LH+6- +10 of the menstrual cycle Figure 4
Immunostaining for pSTAT3 in endometrial glandular epithelium and stroma from normal fertile women and women with pri-
mary infertility between days LH+6- +10 of the menstrual cycle. Relative staining intensities are represented as 0 (no staining) 
to 3 (high). (A) Glandular epithelium. (B) Stroma. Women with primary infertility (infertile) (n = 10). Control normal fertile 
women (fertile) (n = 9). Individual data shown for each parameter. Bar represents the mean value. * P < 0.05 compared to fer-
tile control.
0
0.5
1
1.5
2
2.5
3
3.5
 










	




















0
0.5
1
1.5
2
2.5
3
3.5
 










	




















 

	
 
	Reproductive Biology and Endocrinology 2007, 5:44 http://www.rbej.com/content/5/1/44
Page 8 of 8
(page number not for citation purposes)
Acknowledgements
We thank Dr Lorraine Robb and the Walter and Eliza Hall Institute of Med-
ical Research, for provision of IL-11 and IL-11Rα antibodies. Support for 
this project (ED) was provided by the CICCR Program of the Contracep-
tive Research and Development (CONRAD) Program, Eastern Virginia 
Medical School (Subproject #CIG-02-82) and National Health and Medical 
Research Council of Australia (#388916). The views expressed by the 
authors do not necessarily reflect the views of CICCR or CONRAD. LAS 
was supported by the National Health and Medical Research Council of 
Australia (#143798 and #241000). AS and RS were supported by a grant 
from The Addenbrooke's Charities fund.
References
1. Bulletti C, Flamigni C, Giacomucci E: Reproductive failure due to
spontaneous abortion and recurrent miscarriage.  Hum
Reprod Update 1996, 2:118-136.
2. Psychoyos A: Hormonal control of ovoimplantation.  Vitam
Horm 1973, 31:201-256.
3. Navot D, Scott RT, Droesch K, Veeck LL, Liu HC, Rosenwaks Z: The
window of embryo transfer and the efficiency of human con-
ception in vitro.  Fertil Steril 1991, 55:114-118.
4. Wilcox AJ, Baird DD, Weinberg CR: Time of implantation of the
conceptus and loss of pregnancy.  N Engl J Med 1999,
340:1796-1799.
5. Evers JLH: Female subfertility.  Lancet 2002, 360:151-159.
6. Smith S, Pfeifer SM, Collins J: Diagnosis and management of
female infertility.  JAMA 2003, 290:1767-1770.
7. Lessey BA, Castelbaum AJ, Sawin SW, Sun J: Integrins as markers
of uterine receptivity in women with primary unexplained
infertility.  Fertil Steril 1995, 63(3):535-542.
8. Sharkey AM, Smith SK: The endometrium as a cause of implan-
tation failure.  Best Pract Res Clin Obstet Gynaecol 2003, 17:289-307.
9. Heinrich PC, Behrmann I, Muller-Newen G, Schaper F, Graeve L:
Interleukin-6-type cytokine signalling through the gp130/Jak/
STAT pathway.  Biochem J 1998, 334:297-314.
10. Cheng JG, Chen JR, Hernandez L, Alvord WG, Stewart CL: Dual
control of LIF expression and LIF receptor function regulate
Stat3 activation at the onset of uterine receptivity and
embryo implantation.  Proc Natl Acad Sci USA 2001, 98:8680-8685.
11. Levy DE, Lee CK: What does Stat3 do?  J Clin Invest 2002,
109:1143-1148.
12. Dimitriadis E, Stoikos C, Tan YL, Salamonsen LA: Interleukin 11
signalling components signal transducer and activator of
transcription 3 (STAT3) and suppressor of cytokine signal-
ling 3 (SOCS3) regulate human endometrial stromal cell dif-
ferentiation.  Endocrinology 2006, 147:3809-3817.
13. Wang H, Dey SK: Roadmap to embryo implantation: clues
from mouse models.  Nat Rev Genet 2006, 7:185-199.
14. Bilinski P, Roopenian D, Gossler A: Maternal IL-11Ralpha func-
tion is required for normal decidua and fetoplacental devel-
opment in mice.  Genes Dev 1998, 12:2234-2243.
15. Robb L, Li R, Hartley L, Nandurkar HH, Koentgen F, Begley CG:
Infertility in female mice lacking the receptor for interleukin
11 is due to a defective uterine response to implantation.  Nat
Med 1998, 4:303-308.
16. Stewart CL, Kaspar P, Brunet LJ, Bhatt H, Gadi I, Kontgen F, Abbon-
danzo SJ: Blastocyst implantation depends on maternal
expression of leukaemia inhibitory factor.  Nature 1992,
359:76-79.
17. Ernst M, Inglese M, Waring P, Campbell IK, Bao S, Clay FJ, Alexander
WS, Wicks IP, Tarlinton DM, Novak U, Heath JK, Dunn AR: Defec-
tive gp130-mediated signal transducer and activator of tran-
scription (STAT) signalling results in degenerative joint
disease, gastrointestinal ulceration, and failure of uterine
implantation.  J Exp Med 2001, 194:189-203.
18. Catalano RD, Johnson MH, Campbell EA, Charnock-Jones DS, Smith
SK, Sharkey AM: Inhibition of Stat3 activation in the
endometrium prevents implantation: A nonsteroidal
approach to contraception.  Proc Natl Acad Sci USA 2005,
102:8585-8590.
19. Nakamura H, Kimura T, Koyama S, Ogita K, Tsutsui T, Shimoya , Tan-
iguchi T, Koyama M, Kaneda Y, Murata Y: Mouse model of human
infertility: transient and local inhibition of endometrial
STAT-3 activation results in implantation failure.  FEBS Lett
2006, 580:2717-2722.
20. Robb L, Dimitriadis E, Li R, Salamonsen LA: Leukaemia inhibitory
factor and interleukin-11: cytokines with key roles in implan-
tation.  J Reprod Immunol 2002, 57:129-141.
21. Dimitriadis E, White CA, Jones RL, Salamonsen LA: Cytokines,
chemokines and growth factors in endometrium related to
implantation.  Hum Reprod Update 2005, 11:613-630.
22. Cullinan EB, Abbondanzo SJ, Anderson PS, Pollard JW, Lessey BA,
Stewart CL: Leukaemia inhibitory factor (LIF) and LIF recep-
tor expression in human endometrium suggests a potential
autocrine/paracrine function in regulating embryo implanta-
tion.  Proc Natl Acad Sci USA 1996, 93:3115-3120.
23. Dimitriadis E, Salamonsen L, Robb L: Expression of interleukin-11
during the human menstrual cycle: coincidence with stromal
cell decidualisation and relationship to leukaemia inhibitory
factor and prolactin.  Mol Hum Reprod 2000, 6:907-914.
24. Cork BA, Li TC, Warren MA, Laird SM: Interleukin-11 (IL-11) in
human endometrium: expression throughout the menstrual
cycle and the effects of cytokines on endometrial IL-11 pro-
duction in vitro.  J Reprod Immunol 2001, 50:3-17.
25. Dimitriadis E, Stoikos C, Stafford-Bell M, Clark I, Paiva P, Kovacs G,
Salamonsen LA: Interleukin-11, IL-11 receptoralpha and leu-
kaemia inhibitory factor are dysregulated in endometrium
of infertile women with endometriosis during the implanta-
tion window.  J Reprod Immunol 2006, 69:53-64.
26. Sherwin JR, Smith SK, Wilson A, Sharkey AM: Soluble gp130 is up-
regulated in the implantation window and shows altered
secretion in patients with primary unexplained infertility.  J
Clin Endocrinol Metab 2002, 87:3953-3960.
27. Karpovich N, Chobotova K, Carver J, Heath JK, Barlow D, Mardon
HJ: Expression and function of interleukin-11 and its receptor
alpha in the human endometrium.  Mol Hum Reprod 2003,
9:75-80.
28. Tsai HD, Chang CC, Hsieh YY, Lo HY: Leukaemia inhibitory fac-
tor expression in different endometrial locations between
fertile and infertile women throughout different menstrual
phases.  J Assist Reprod Genet 2000, 17:415-418.
29. Laird SM, Tuckerman EM, Dalton CF, Dunphy BC, Li TC, Zhang X:
The production of leukaemia inhibitory factor by human
endometrium: presence in uterine flushings and production
by cells in culture.  Hum Reprod 1997, 12:569-574.
30. Ledee-Bataille N, Lapree-Delage G, Taupin JL, Dubanchet S, Frydman
R, Chaouat G: Concentration of leukaemia inhibitory factor
(LIF) in uterine flushing fluid is highly predictive of embryo
implantation.  Hum Reprod 2002, 17:213-218.
31. Mikolajczyk M, Wirstlein P, Skrzypczak J: Leukaemia inhibitory
factor and interleukin 11 levels in uterine flushings of infer-
tile patients with endometriosis.  Hum Reprod 2006,
21:3054-3058.
32. Makkar G, Ng EH, Yeung WS, Ho PC: Reduced expression of
interleukin-11 and interleukin-6 in the periimplantation
endometrium of excessive ovarian responders during in
vitro fertilization treatment.  J Clin Endocrinol Metab 2006,
91:3181-3188.
33. Noyes RW, Hertig AT, Rock J: Dating the Endometrial Biopsy.
Fertil Steril 1950, 1:3-25.
34. Proietti C, Salatino M, Rosemblit C, Carnevale R, Pecci A, Kornblihtt
AR, Molinolo AA, Frahm I, Charreau EH, Schillaci R, Elizalde PV: Pro-
gestins induce transcriptional activation of signal transducer
and activator of transcription 3 (Stat3) via a Jak- and Src-
dependent mechanism in breast cancer cells.  Mol Cell Biol
2005, 25:4826-4840.
35. Sharkey AM, Dellow K, Blayney M, Macnamee M, Charnock-Jones S,
Smith SK: Stage-specific expression of cytokine and receptor
messenger ribonucleic acids in human preimplantation
embryos.  Biol Reprod 1995, 53:974-981.